Armistice Capital, LLC Natera, Inc. Transaction History

Armistice Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $18.9 Million - $29.9 Million	672,000 New	672,000 $23.8 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $9.58 Million - $28.9 Million	-316,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $8.63 Million - $11.9 Million	100,000 Added 46.3%	316,000 $29.5 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $801,360 - $1.01 Million	-8,000 Reduced 3.57%	216,000 $24.1 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $2.07 Million - $2.87 Million	-24,000 Reduced 9.68%	224,000 $25.4 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $12.1 Million - $16.4 Million	132,000 Added 113.79%	248,000 $25.2 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $7.73 Million - $13 Million	116,000 New	116,000 $11.5 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.